Filing Flows › Comparisons › ADCT vs FBIO
ADC Therapeutics SA vs Fortress Biotech: ADCT and FBIO compared
ADC Therapeutics SA is the larger company: $19.2M of revenue in its latest quarter (Q2 2026) against $18.7M for Fortress Biotech (Q2 2026). Fortress Biotech is growing faster (+14% against +2% a year earlier). Fortress Biotech is more profitable, with an operating margin of -53.5% against -132.0%.
Where the money goes: ADCT and FBIO
ADC Therapeutics SA (ADCT) · Q2 2026
ADC Therapeutics SA, Q2 2026: revenue $19.2M (+2% year over year), operating margin -132.0%, net loss $16.6M, operating cash flow −$11.8M. The chart follows the revenue to costs, profit and cash.
Fortress Biotech (FBIO) · Q2 2026
Fortress Biotech, Q2 2026: revenue $18.7M (+14% year over year), operating margin -53.5%, net earnings $602K, operating cash flow −$59.3M. The chart follows the revenue to costs, profit and cash.
| ADC Therapeutics SA (ADCT) | Fortress Biotech (FBIO) | |
|---|---|---|
| Latest quarter | Q2 2026 | Q2 2026 |
| Revenue | $19.2M | $18.7M |
| Revenue growth, Y/Y | +2% | +14% |
| Operating margin | -132.0% | -53.5% |
| Net earnings | −$16.6M | $602K |
| Net margin | -86.1% | 3.2% |
| Operating cash flow | −$11.8M | −$59.3M |
Where the revenue comes from
ADC Therapeutics SA
- Product revenues, net: $18.6M (97%)
- Royalties: $614K (3%)
Fortress Biotech
- Journey: $18.5M (99%)
- Fortress: $208K (1%)
Questions
Which is bigger, ADC Therapeutics SA or Fortress Biotech?
ADC Therapeutics SA is the larger company: $19.2M of revenue in its latest quarter (Q2 2026) against $18.7M for Fortress Biotech (Q2 2026).
Is ADC Therapeutics SA or Fortress Biotech growing faster?
Fortress Biotech is growing faster (+14% against +2% a year earlier).
Which is more profitable, ADC Therapeutics SA or Fortress Biotech?
Fortress Biotech is more profitable, with an operating margin of -53.5% against -132.0%.
More: ADC Therapeutics SA earnings · how ADC Therapeutics SA makes money · Fortress Biotech earnings · how Fortress Biotech makes money
From the companies' latest 10-Q, 10-K or earnings release (10-Q filed Aug 13, 2026; 10-Q filed Aug 13, 2026). Fiscal quarters can end on different dates. Not investment advice.